AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 66 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $16,000 | -23.8% | 22,440 | -12.9% | 0.00% | – |
| Q1 2019 | $21,000 | -30.0% | 25,761 | +38.4% | 0.00% | – |
| Q4 2018 | $30,000 | -53.8% | 18,616 | -34.4% | 0.00% | – |
| Q2 2018 | $65,000 | +35.4% | 28,399 | +72.5% | 0.00% | – |
| Q1 2018 | $48,000 | -31.4% | 16,467 | -35.0% | 0.00% | – |
| Q4 2017 | $70,000 | +141.4% | 25,323 | -27.0% | 0.00% | – |
| Q4 2014 | $29,000 | -76.0% | 34,680 | -47.5% | 0.00% | – |
| Q2 2014 | $121,000 | +181.4% | 66,072 | +130.4% | 0.00% | – |
| Q1 2014 | $43,000 | -70.7% | 28,677 | -64.3% | 0.00% | – |
| Q4 2013 | $147,000 | +67.0% | 80,217 | +87.1% | 0.00% | – |
| Q3 2013 | $88,000 | -95.8% | 42,883 | -94.9% | 0.00% | -100.0% |
| Q2 2013 | $2,102,000 | +42.0% | 841,034 | +317.4% | 0.00% | +100.0% |
| Q1 2013 | $1,480,000 | – | 201,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 25,243,865 | $21,318,000 | 1.76% |
| X-Square Capital, LLC | 652,605 | $551,000 | 0.35% |
| 683 Capital Management, LLC | 1,978,723 | $1,671,000 | 0.19% |
| WealthTrust Axiom LLC | 138,085 | $116,000 | 0.04% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $43,000 | 0.04% |
| Caption Management, LLC | 748,200 | $632,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 125,346 | $106,000 | 0.01% |
| Larson Financial Group LLC | 26,475 | $22,000 | 0.01% |
| Virtu Financial LLC | 164,673 | $139,000 | 0.01% |
| Evercore Wealth Management, LLC | 418,414 | $353,000 | 0.01% |